Article citationsMore>>

Phillips, L.E., McLintock, C., Pollock, W., Gatt, S., Popham, P., Jankelowitz, G., Ogle, R. and Cameron, P.A. (2009) Australian and New Zealand Haemostasis Registry: Recombinant Activated Factor VII in Obstetric Hemorrhage: Experiences from the Australian and New Zealand Haemostasis Registry. Anesthesia & Analgesia, 109, 1908-1915. http://dx.doi.org/10.1213/ANE.0b013e3181c039e6

has been cited by the following article:

• TITLE: A Survey of Current Treatment Practices for Postpartum Hemorrhage by Practicing Obstetricians and Hematologists

  AUTHORS: Elizabeth W. Triche, Mark J. Wehrum, Michael J. Paidas

  KEYWORDS: Postpartum Hemorrhage; Physician Survey; Recombinant Factor VIIa; Clinical Management

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.4 No.6, April 15, 2014

  ABSTRACT: Objective: To identify current treatment strategies for postpartum hemorrhage used by obstetricians (OB/GYNs) and hematologists (HEMs). Study Design: We conducted a survey of OB/GYNs (n = 220) and HEMs (n = 30) to describe the characteristics of current treatment strategies for postpartum hemorrhage. Surveys were administered via a structured questionnaire on a secure internet website from 5 - 12 October 2009. Results: The majority of OB/GYN and HEM respondents were practicing in a community hospital environment (77%). Of the OB/GYNs, the majority practiced at hospitals with over 2000 deliveries per year (77%). A majority (58%) of OB/GYNs were affiliated with hospitals that lacked a massive transfusion protocol to treat severe postpartum hemorrhage. Subsequent to uterine massage and additional oxytocin, the majority of OB/GYNs (73%), preferred the administration of Methergine? as the next level of intervention for postpartum hemorrhage. There was considerable variability in response to specific treatment strategies for several hypothetical case scenarios; however, the large majority of OB/GYNs favored obstetrical procedures over interventional radiology or administration of rFVIIa. A large majority (77%) of physicians who are familiar with rRVIIa as treatment for postpartum hemorrhage reported being very satisfied with the agent for this indication. Conclusions: An established, systematic treatment strategy among OB/GYNs emerged only in the case of mild postpartum hemorrhage.